AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. K
  4. [Form 4] Kellanova Insider Trading Activity

[Form 4] Kellanova Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary

Form 4 filing for Kellanova (K): On 07/21/2025 the W.K. Kellogg Foundation Trust, a 10 % beneficial owner, sold 114,583 common shares at $79.92. Post-sale holding is 45,670,369 shares, so the divestiture reduces its stake by roughly 0.25 %. The sales were executed under a pre-arranged Rule 10b5-1 plan adopted 05/07/2024. No derivative securities were involved and no other insiders transacted.

The filing provides no earnings data or strategic commentary; it simply discloses a routine, plan-based share sale by the Trust鈥檚 corporate trustees.

Deposito del modulo 4 per Kellanova (K): Il 21/07/2025, la W.K. Kellogg Foundation Trust, detentrice del 10% dei diritti, ha venduto 114.583 azioni ordinarie a 79,92 $. Dopo la vendita, la partecipazione 猫 di 45.670.369 azioni, quindi la cessione riduce la quota di circa lo 0,25%. Le vendite sono state effettuate nell'ambito di un piano predefinito secondo la Regola 10b5-1 adottato il 07/05/2024. Non sono stati coinvolti titoli derivati e nessun altro insider ha effettuato transazioni.

Il deposito non fornisce dati sugli utili n茅 commenti strategici; si limita a comunicare una vendita di azioni di routine, basata su un piano, da parte dei fiduciari aziendali del Trust.

Presentaci贸n del formulario 4 para Kellanova (K): El 21/07/2025, el W.K. Kellogg Foundation Trust, propietario beneficiario del 10%, vendi贸 114,583 acciones comunes a $79.92. Tras la venta, la tenencia es de 45,670,369 acciones, por lo que la desinversi贸n reduce su participaci贸n en aproximadamente un 0,25%. Las ventas se realizaron bajo un plan preestablecido conforme a la Regla 10b5-1 adoptado el 07/05/2024. No se involucraron valores derivados y ning煤n otro insider realiz贸 transacciones.

La presentaci贸n no incluye datos de ganancias ni comentarios estrat茅gicos; simplemente revela una venta rutinaria de acciones basada en un plan por parte de los fiduciarios corporativos del Trust.

Kellanova (K)鞚� Form 4 鞝滌稖: 2025雲� 7鞗� 21鞚�, 10% 歆�攵勳潉 氤挫湢頃� W.K. Kellogg Foundation Trust臧� 氤错喌欤� 114,583欤茧ゼ 欤茧嫻 79.92雼煬鞐� 毵る弰頄堨姷雼堧嫟. 毵る弰 頉� 氤挫湢 欤检嫕鞚� 45,670,369欤�搿�, 鞚措矆 毵る弰電� 鞎� 0.25% 歆�攵� 臧愳唽毳� 鞚橂頃╇媹雼�. 毵る弰電� 2024雲� 5鞗� 7鞚� 毂勴儩霅� 靷爠 瓿勴殟霅� Rule 10b5-1 瓿勴殟鞐� 霐半澕 鞁ろ枆霅橃棃鞀惦媹雼�. 韺岇儩 歃濌秾鞚� 韽暔霅橃 鞎婌晿鞙茧┌ 雼るジ 雮措秬鞛� 瓯半灅霃� 鞐嗢棃鞀惦媹雼�.

鞚措矆 鞝滌稖 靹滊電� 靾橃澋 雿办澊韯半倶 鞝勲灥鞝� 雲柬弶鞚� 韽暔頃橃 鞎婌溂氅�, 雼 鞁犿儊鞚� 氩曥澑 靾橅儊鞛愲摛鞚� 瓿勴殟鞐� 霐半澕 鞁れ嫓頃� 鞚检儊鞝侅澑 欤检嫕 毵る弰 靷嫟毵岇潉 瓿奠嫓頃╇媹雼�.

D茅p么t du formulaire 4 pour Kellanova (K) : Le 21/07/2025, le W.K. Kellogg Foundation Trust, d茅tenteur b茅n茅ficiaire de 10 %, a vendu 114 583 actions ordinaires 脿 79,92 $. Apr猫s la vente, la participation s鈥櫭﹍猫ve 脿 45 670 369 actions, ce qui r茅duit sa part d鈥檈nviron 0,25 %. Les ventes ont 茅t茅 effectu茅es dans le cadre d鈥檜n plan pr茅茅tabli selon la r猫gle 10b5-1 adopt茅 le 07/05/2024. Aucun titre d茅riv茅 n鈥檃 茅t茅 impliqu茅 et aucun autre initi茅 n鈥檃 r茅alis茅 de transactions.

Le d茅p么t ne fournit aucune donn茅e sur les b茅n茅fices ni commentaire strat茅gique ; il se contente de divulguer une vente d鈥檃ctions de routine, bas茅e sur un plan, r茅alis茅e par les administrateurs corporatifs du Trust.

Formular 4 Einreichung f眉r Kellanova (K): Am 21.07.2025 verkaufte der W.K. Kellogg Foundation Trust, ein 10%iger wirtschaftlicher Eigent眉mer, 114.583 Stammaktien zum Preis von 79,92 $. Nach dem Verkauf h盲lt der Trust 45.670.369 Aktien, wodurch der Anteil um etwa 0,25 % reduziert wird. Die Verk盲ufe erfolgten im Rahmen eines vorab vereinbarten Rule 10b5-1 Plans, der am 07.05.2024 angenommen wurde. Es waren keine Derivate beteiligt und keine weiteren Insider t盲tigten Transaktionen.

Die Einreichung enth盲lt keine Gewinnzahlen oder strategische Kommentare; sie gibt lediglich einen routinem盲脽igen, planbasierten Aktienverkauf durch die Unternehmens-Treuh盲nder des Trusts bekannt.

Positive
  • Sale executed under a Rule 10b5-1 plan, mitigating information-asymmetry concerns and demonstrating compliance with insider-trading safeguards.
Negative
  • Insider selling by a 10 % owner can be perceived as a modestly negative sentiment signal even though the percentage sold is small.

Insights

TL;DR: Small 10%-owner sale under 10b5-1; negligible dilution, slightly negative sentiment.

The Trust sold 114.6k shares鈥攐nly 0.25 % of its 45.7 m-share position鈥攊ndicating portfolio rebalancing rather than an adverse view on fundamentals. Use of a Rule 10b5-1 plan reduces information-risk, limiting market impact. Given Kellanova鈥檚 average daily volume (~2 m shares), the trade represents about 6 % of one day鈥檚 liquidity and should be easily absorbed. I view the disclosure as low impact and slightly negative from a sentiment perspective, but not thesis-changing.

TL;DR: Governance-compliant, pre-planned insider sale; minimal governance concern.

The Trust remains a >10 % holder after the transaction, preserving significant alignment with public shareholders. Execution through a 10b5-1 plan, in place since May 2024, signals adherence to best-practice insider trading controls. No new powers, pledges or derivative positions were disclosed. Consequently, I deem the event not materially impactful for governance risk assessments.

Deposito del modulo 4 per Kellanova (K): Il 21/07/2025, la W.K. Kellogg Foundation Trust, detentrice del 10% dei diritti, ha venduto 114.583 azioni ordinarie a 79,92 $. Dopo la vendita, la partecipazione 猫 di 45.670.369 azioni, quindi la cessione riduce la quota di circa lo 0,25%. Le vendite sono state effettuate nell'ambito di un piano predefinito secondo la Regola 10b5-1 adottato il 07/05/2024. Non sono stati coinvolti titoli derivati e nessun altro insider ha effettuato transazioni.

Il deposito non fornisce dati sugli utili n茅 commenti strategici; si limita a comunicare una vendita di azioni di routine, basata su un piano, da parte dei fiduciari aziendali del Trust.

Presentaci贸n del formulario 4 para Kellanova (K): El 21/07/2025, el W.K. Kellogg Foundation Trust, propietario beneficiario del 10%, vendi贸 114,583 acciones comunes a $79.92. Tras la venta, la tenencia es de 45,670,369 acciones, por lo que la desinversi贸n reduce su participaci贸n en aproximadamente un 0,25%. Las ventas se realizaron bajo un plan preestablecido conforme a la Regla 10b5-1 adoptado el 07/05/2024. No se involucraron valores derivados y ning煤n otro insider realiz贸 transacciones.

La presentaci贸n no incluye datos de ganancias ni comentarios estrat茅gicos; simplemente revela una venta rutinaria de acciones basada en un plan por parte de los fiduciarios corporativos del Trust.

Kellanova (K)鞚� Form 4 鞝滌稖: 2025雲� 7鞗� 21鞚�, 10% 歆�攵勳潉 氤挫湢頃� W.K. Kellogg Foundation Trust臧� 氤错喌欤� 114,583欤茧ゼ 欤茧嫻 79.92雼煬鞐� 毵る弰頄堨姷雼堧嫟. 毵る弰 頉� 氤挫湢 欤检嫕鞚� 45,670,369欤�搿�, 鞚措矆 毵る弰電� 鞎� 0.25% 歆�攵� 臧愳唽毳� 鞚橂頃╇媹雼�. 毵る弰電� 2024雲� 5鞗� 7鞚� 毂勴儩霅� 靷爠 瓿勴殟霅� Rule 10b5-1 瓿勴殟鞐� 霐半澕 鞁ろ枆霅橃棃鞀惦媹雼�. 韺岇儩 歃濌秾鞚� 韽暔霅橃 鞎婌晿鞙茧┌ 雼るジ 雮措秬鞛� 瓯半灅霃� 鞐嗢棃鞀惦媹雼�.

鞚措矆 鞝滌稖 靹滊電� 靾橃澋 雿办澊韯半倶 鞝勲灥鞝� 雲柬弶鞚� 韽暔頃橃 鞎婌溂氅�, 雼 鞁犿儊鞚� 氩曥澑 靾橅儊鞛愲摛鞚� 瓿勴殟鞐� 霐半澕 鞁れ嫓頃� 鞚检儊鞝侅澑 欤检嫕 毵る弰 靷嫟毵岇潉 瓿奠嫓頃╇媹雼�.

D茅p么t du formulaire 4 pour Kellanova (K) : Le 21/07/2025, le W.K. Kellogg Foundation Trust, d茅tenteur b茅n茅ficiaire de 10 %, a vendu 114 583 actions ordinaires 脿 79,92 $. Apr猫s la vente, la participation s鈥櫭﹍猫ve 脿 45 670 369 actions, ce qui r茅duit sa part d鈥檈nviron 0,25 %. Les ventes ont 茅t茅 effectu茅es dans le cadre d鈥檜n plan pr茅茅tabli selon la r猫gle 10b5-1 adopt茅 le 07/05/2024. Aucun titre d茅riv茅 n鈥檃 茅t茅 impliqu茅 et aucun autre initi茅 n鈥檃 r茅alis茅 de transactions.

Le d茅p么t ne fournit aucune donn茅e sur les b茅n茅fices ni commentaire strat茅gique ; il se contente de divulguer une vente d鈥檃ctions de routine, bas茅e sur un plan, r茅alis茅e par les administrateurs corporatifs du Trust.

Formular 4 Einreichung f眉r Kellanova (K): Am 21.07.2025 verkaufte der W.K. Kellogg Foundation Trust, ein 10%iger wirtschaftlicher Eigent眉mer, 114.583 Stammaktien zum Preis von 79,92 $. Nach dem Verkauf h盲lt der Trust 45.670.369 Aktien, wodurch der Anteil um etwa 0,25 % reduziert wird. Die Verk盲ufe erfolgten im Rahmen eines vorab vereinbarten Rule 10b5-1 Plans, der am 07.05.2024 angenommen wurde. Es waren keine Derivate beteiligt und keine weiteren Insider t盲tigten Transaktionen.

Die Einreichung enth盲lt keine Gewinnzahlen oder strategische Kommentare; sie gibt lediglich einen routinem盲脽igen, planbasierten Aktienverkauf durch die Unternehmens-Treuh盲nder des Trusts bekannt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
KELLOGG W K FOUNDATION TRUST
(Last) (First) (Middle)
ONE MICHIGAN AVE. EAST
(Street)
BATTLE CREEK MI 49017
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KELLANOVA [ K ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/21/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/21/2025 07/21/2025 S 114,583 D $79.92 45,670,369(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
KELLOGG W K FOUNDATION TRUST
(Last) (First) (Middle)
ONE MICHIGAN AVE. EAST
(Street)
BATTLE CREEK MI 49017
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
KELLOGG W K FOUNDATION
(Last) (First) (Middle)
ONE MICHIGAN AVENUE EAST
(Street)
BATTLE CREEK MI 49017
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. 45,670,369 shares were owned following the reported transaction by the W.K. Kellogg Foundation Trust (the "Trust") of which LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas and The Northern Trust Company are Trustees and the W.K. Kellogg Foundation (the "Foundation") is the sole beneficiary.
Remarks:
The sales reported on this Form 4 were made pursuant to trading instructions given by the W.K. Kellogg Foundation Trust on May 7, 2024 that are intended to comply with Rule 10b5-1(c) under the Securities and Exchange Act of 1934.
Craig R. Carberry, Deputy General Counsel, The Northern Trust Company, as Corporate Trustee of the W.K. Kellogg Foundation Trust and signing for the W.K. Kellogg Foundation pursuant to a Power of Attorney dated August 30, 2017 07/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

Who sold Kellanova (K) shares on 07/21/2025?

The W.K. Kellogg Foundation Trust, a 10 % beneficial owner, executed the sale.

How many Kellanova shares were sold in the Form 4 filing?

A total of 114,583 common shares were sold.

At what price were the Kellanova shares sold?

The shares were sold at $79.92 per share.

How many Kellanova shares does the W.K. Kellogg Foundation Trust own after the sale?

It continues to hold 45,670,369 shares.

Was the Kellanova insider sale pre-planned?

Yes. The Trust鈥檚 transactions were made under a Rule 10b5-1 trading plan adopted on 05/07/2024.

Does the filing mention derivative securities or additional transactions?

No. Table II is blank, indicating no derivative transactions.
Stock K logo
Kellanova

NYSE:K

K Rankings

#593 Ranked by Market Cap
#1132 Ranked by Dividends

K Latest News

Jul 25, 2025
Kellanova Declares Regular Dividend of $0.58 per Share for Third Quarter
Jul 21, 2025
Nutri-Grain Launches "Not Sorry" Campaign with AG真人官方ity TV's Most Unapologetic Stars
Jul 14, 2025
CHEEZ-IT庐 BRINGS ITS A-GAME TO THE BASKETBALL 'TUNNEL FIT' TREND WITH SNACK-INSPIRED PIECES
Jun 25, 2025
Mars鈥� Pending Acquisition of Kellanova Clears FTC Antitrust Review
Jun 16, 2025
CHEEZ-IT庐 AND PRINGLES庐 ARE FAVORITE ROAD TRIP SNACKS ACROSS GENERATIONS, NEW SURVEY FINDS

K Latest SEC Filings

Jul 23, 2025
[Form 4/A] Kellanova Amended Insider Trading Activity
Jul 22, 2025
[144] Kellanova SEC Filing
Jul 18, 2025
[144] Kellanova SEC Filing
Jul 14, 2025
[Form 4] Kellanova Insider Trading Activity
Jul 7, 2025
[Form 4] Kellanova Insider Trading Activity

K Stock Data

27.72B
344.99M
0.96%
82.32%
1.91%
Packaged Foods
Grain Mill Products
United States
CHICAGO